Tagrid Antifungal Treament Clotrimazole 1%

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Tagrid Antifungal Treament Clotrimazole 1%
Generic name
CLOTRIMAZOLE
Manufacturer
TAGRID LLC
Product type
HUMAN OTC DRUG
SPL set ID
dff03e98-e2cf-4427-a87a-a7da1b04b3b6
SPL ID
a0037866-2dd8-4cb1-bc32-e8bda0527f69
Version
2
Effective date
2025-07-09
Source export date
2026-09-28
Source partition
14
Source file
https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:40:01
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. on broken, inflamed, or severely irritated skin. lf you are allergic to Clotrimazole or any other ingredients in this product. Avoid contact with the eyes. If the product gets into the eyes, rinse thoroughly with water. Stop use and ask a doctor if: a rash appears. the condition does not improve within 2-4 weeks of regular use. ask a healthcare provider before use. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.